Melinda C. Power

Melinda C. Power

Auto-generated profile, based on publicly available information

Melinda C. Power

Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington DC

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 March 2015 in BMJ
Verified
Journal Article
Open access
PDF file
MPMelinda C Power
Melinda C Power
MKMarianthi-Anna Kioumourtzoglou
Marianthi-Anna Kioumourtzoglou
JHJaime E Hart
Jaime E Hart
OOOlivia I Okereke
Olivia I Okereke
FLFrancine Laden
Francine Laden
MWMarc G Weisskopf
Marc G Weisskopf
Objective To determine whether higher past exposure to particulate air pollution is associated with prevalent high symptoms of anxiety. Design Observational cohort study. Setting Nurses’ Health Study. Participants 71 271 women enrolled in the Nurses’ Health Study residing throughout the contiguous United States who had valid estimates on exposure to particulate matter for at least one exposure period of interest and data on anxiety symptoms. Main outcome measures Meaningfully high symptoms of anxiety, defined as a score of 6 points or greater on the phobic anxiety subscale of the Crown-Crisp index, administered in 2004. Results The 71 271 eligible women were aged between 57 and 85 years (mean 70 years) at the time of assessment of anxiety symptoms, with a prevalence of high anxiety symptoms of 15%. Exposure to particulate matter was characterized using estimated average exposure to particulate matter <2.5 μm in diameter (PM2.5) and 2.5 to 10 μm in diameter (PM2.5-10) in the one month, three months, six months, one year, and 15 years prior to assessment of anxiety symptoms, and residential distance to the nearest major road two years prior to assessment. Significantly increased odds of high anxiety symptoms were observed with higher exposure to PM2.5 for multiple averaging periods (for example, odds ratio per 10 µg/m3 increase in prior one month average PM2.5: 1.12, 95% confidence interval 1.06 to 1.19; in prior 12 month average PM2.5: 1.15, 1.06 to 1.26). Models including multiple exposure windows suggested short term averaging periods were more relevant than long term averaging periods. There was no association between anxiety and exposure to PM2.5-10. Residential proximity to major roads was not related to anxiety symptoms in a dose dependent manner. Conclusions Exposure to fine particulate matter (PM2.5) was associated with high symptoms of anxiety, with more recent exposures potentially more relevant than more distant exposures. Research evaluating whether reductions in exposure to ambient PM2.5 would reduce the population level burden of clinically relevant symptoms of anxiety is warranted.

26 June 2018 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
MPMelinda C. Power
Melinda C. Power
EMElizabeth Mormino
Elizabeth Mormino
ASAnja Soldan
Anja Soldan
BJBryan D. James
Bryan D. James
LYLei Yu
Lei Yu
JSJulie Schneider
Julie Schneider

1 September 2021 in Environmental Health Perspectives
Verified
Journal Article
Closed access
JWJennifer Weuve
Jennifer Weuve
EBErin E. Bennett
Erin E. Bennett
LRLynsie Ranker
Lynsie Ranker
KGKan Z. Gianattasio
Kan Z. Gianattasio
MPMeredith Pedde
Meredith Pedde
MPMelinda C. Power
Melinda C. Power

1 January 2019 in Alzheimer's & Dementia: Translational Research & Clinical Interventions
Verified
Journal Article
Open access
KGKan Z. Gianattasio
Kan Z. Gianattasio
CPChristina Prather
Christina Prather
MGM. Maria Glymour
M. Maria Glymour
ACAdam Ciarleglio
Adam Ciarleglio
MPMelinda C. Power
Melinda C. Power
Introduction: Systematic disparities in misdiagnosis of dementia across racial/ethnic groups have implications for health disparities. We compared the risk of dementia under‐ and overdiagnosis in clinical settings across racial/ethnic groups from 2000 to 2010. Methods: We linked fee‐for‐service Medicare claims to participants aged ≥70 from the nationally representative Health and Retirement Study. We classified dementia status using an algorithm with similar sensitivity and specificity across racial/ethnic groups and assigned clinical dementia diagnosis status using ICD‐9‐CM codes from Medicare claims. Multinomial logit models were used to estimate relative risks of clinical under‐ and overdiagnosis between groups and over time. Results: Non‐Hispanic blacks had roughly double the risk of underdiagnosis as non‐Hispanic whites. While primary analyses suggested a shrinking disparity over time, this was not robust to sensitivity analyses or adjustment for covariates. Risk of overdiagnosis increased over time in both groups. Discussion: Our results suggest that efforts to reduce racial disparities in underdiagnosis are warranted.

1 March 2021 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
MPMelinda C. Power
Melinda C. Power
EBErin E. Bennett
Erin E. Bennett
RTRobert W. Turner
Robert W. Turner
NDN. Maritza Dowling
N. Maritza Dowling
ACAdam Ciarleglio
Adam Ciarleglio
KGKan Z. Gianattasio
Kan Z. Gianattasio
In the US, multiple studies report that the risk of dementia is higher in non-Hispanic Black individuals than in non-Hispanic White individuals.1-3 These disparities mirror those in other health domains, which are broadly attributed to the cumulative effects of structural racism4; likewise, structural racism may affect brain health through material, behavioral, and biological mechanisms.5-9 To address this concern, the US National Alzheimer Project Act10 established the National Alzheimer Project to achieve several goals, including to “…decrease disparities in Alzheimer's [sic] disease for racial and ethnic minority populations that are at higher risk for Alzheimer's disease.”11